ALPHATIME ACQUISITION CORP: Nasdaq/NYSE listing notice — AlphaTime Acquisition Corp (ATMC) receives Nasdaq delisting notice for failing $50M market value requirement

ALPHATIME ACQUISITION CORP

Received Nasdaq notice on April 17, 2025; MVLS below $50M for 30 consecutive business days.
Has until October 14, 2025 (180 days) to regain compliance by closing at $50M+ for 10 consecutive days.
If not compliant, ordinary shares may be delisted; company can appeal or apply to transfer to Nasdaq Capital Market.
Company will monitor MVLS and evaluate options, but no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ALPHATIME ACQUISITION CORP received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: market value
Rules: 5450(b)(2)(A)

Exact text from the filing

April 17, 2025, AlphaTime Acquisition Corp (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defined by Nasdaq (“ MVLS ”), of the Company’s ordinary shares, par value $0.0001 per share (the “ Ordinary Shares ”), has been below the minimum $50 million requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “ Minimum Market Value of Listed Secur

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001641172-25-005551

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.